High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders.
暂无分享,去创建一个
[1] J. Luong,et al. Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat. , 2019, Biotechnology advances.
[2] G. Avery. Biotin interference in immunoassay: a review for the laboratory scientist , 2019, Annals of clinical biochemistry.
[3] L. de Koning,et al. Strategies for mitigating risk posed by biotin interference on clinical immunoassays. , 2019, Clinical biochemistry.
[4] T. Bednarczuk,et al. The effect of biotin interference on the results of blood hormone assays. , 2019, Endokrynologia Polska.
[5] H. Luu,et al. Further assessment of the prevalence of biotin supplementation and its impact on risk. , 2019, Clinical Biochemistry.
[6] E. Wagar,et al. Comprehensive assessment of biotin interference in immunoassays. , 2018, Clinica chimica acta; international journal of clinical chemistry.
[7] A. Mattman,et al. Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM) , 2018, Reviews in Endocrine and Metabolic Disorders.
[8] S. Lipner. Rethinking biotin therapy for hair, nail, and skin disorders. , 2018, Journal of the American Academy of Dermatology.
[9] S. Lipner,et al. Biotin for the treatment of nail disease: what is the evidence? , 2018, The Journal of dermatological treatment.
[10] K. Sikaris,et al. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin–biotin immunoassays , 2018, Annals of clinical biochemistry.
[11] K. Sikaris,et al. Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays , 2018, Annals of clinical biochemistry.
[12] M. Duchowny,et al. Biotin and Acetazolamide for Treatment of an Unusual Child With Autism Plus Lack of Nail and Hair Growth. , 2017, Pediatric neurology.
[13] P. Y. Zhang,et al. [Biotin-thiamine-responsive basal ganglia disease]. , 2018, Zhonghua er ke za zhi = Chinese journal of pediatrics.
[14] M. Emanuele,et al. Biotin Interference in Clinical Immunoassays: A Cause for Concern. , 2017, Archives of pathology & laboratory medicine.
[15] A. Imbard,et al. Adult-onset biotinidase deficiency: two individuals with severe, but reversible optic neuropathy , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[16] N. Frey,et al. Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference , 2017 .
[17] P. Chanson,et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference , 2017, Clinical chemistry and laboratory medicine.
[18] Vinita Singh,et al. BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[19] L. Lam,et al. A simple method to detect biotin interference on immunoassays , 2017, Clinical chemistry and laboratory medicine.
[20] L. Castelo-Soccio,et al. A Review of the Use of Biotin for Hair Loss , 2017, Skin Appendage Disorders.
[21] B. Wolf. Successful outcomes of older adolescents and adults with profound biotinidase deficiency identified by newborn screening , 2016, Genetics in Medicine.
[22] G. Birnbaum,et al. High dose biotin as treatment for progressive multiple sclerosis. , 2016, Multiple sclerosis and related disorders.
[23] B. Wolf,et al. Irreversibility of Symptoms with Biotin Therapy in an Adult with Profound Biotinidase Deficiency. , 2017, JIMD reports.
[24] H. Said,et al. Mutations in SLC5A6 associated with brain, immune, bone, and intestinal dysfunction in a young child , 2017, Human Genetics.
[25] M. Clanet,et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study , 2016, Multiple sclerosis.
[26] F. Distelmaier,et al. Biotin Treatment Mimicking Graves' Disease. , 2016, The New England journal of medicine.
[27] P. Laurberg,et al. Biochemical Hyperthyroidism in a Newborn Baby Caused by Assay Interaction from Biotin Intake , 2016, European Thyroid Journal.
[28] D. Mock,et al. Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis , 2016, Expert opinion on drug metabolism & toxicology.
[29] R. Sulaiman. Biotin treatment causing erroneous immunoassay results: A word of caution for clinicians. , 2016, Drug discoveries & therapeutics.
[30] M. Alfadhel,et al. Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[31] K. Pindolia,et al. Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood , 2015, Multiple sclerosis.
[32] B. Wolf. Clinical issues and frequent questions about biotinidase deficiency. , 2010, Molecular genetics and metabolism.
[33] S. Sobki,et al. Interference by Biotin Therapy on Measurement of TSH and FT4 by Enzymeimmunoassay on Boehringer Mannheim ES700 Analyser , 1996, Annals of clinical biochemistry.
[34] B. Wolf,et al. Biotinidase Deficiency a , 1985, Advances in pediatrics.
[35] B. Wolf,et al. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[36] L. Surh,et al. Evidence for a defect of holocarboxylase synthetase activity in cultured lymphoblasts from a patient with biotin-responsive multiple carboxylase deficiency. , 1982, American journal of human genetics.
[37] W. Nyhan,et al. Mutant holocarboxylase synthetase: evidence for the enzyme defect in early infantile biotin-responsive multiple carboxylase deficiency. , 1981, The Journal of clinical investigation.
[38] D. Crowell,et al. Multiple carboxylase deficiency: clinical and biochemical improvement following neonatal biotin treatment. , 1981, Pediatrics.